JWH-258

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms	[[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704	[[File:|50px]]
References

JWH-258 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is a member of the naphthoylindole family of compounds, which were originally developed for research purposes to study the endocannabinoid system.

Chemical Structure and Properties

JWH-258 is chemically classified as a naphthoylindole, with the systematic IUPAC name 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole. The compound has a molecular formula of C₂₅H₂₅NO₂ and a molar mass of 371.47 g/mol. The structure consists of a naphthalene ring system attached to an indole core, with a methoxy group at the 4-position of the naphthalene ring and a pentyl chain at the 1-position of the indole.

Pharmacology

JWH-258 is known to bind to the CB₁ and CB₂ cannabinoid receptors, with a higher affinity for the CB₁ receptor. This binding mimics the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. As a result, JWH-258 can produce similar psychoactive effects, including euphoria, altered perception, and relaxation.

Legal Status

Due to its psychoactive properties and potential for abuse, JWH-258 has been classified as a controlled substance in many countries. It is often included in the list of substances banned under synthetic cannabinoid legislation, which aims to regulate compounds that mimic the effects of cannabis.

Research and Applications

JWH-258, like other synthetic cannabinoids, was initially developed for scientific research to explore the endocannabinoid system and its role in various physiological processes. These compounds have been used to study receptor binding, signal transduction, and the potential therapeutic applications of cannabinoid receptor modulation.

Health Effects and Risks

The use of JWH-258 and other synthetic cannabinoids has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, anxiety, and hallucinations. The variability in potency and the lack of quality control in illicit products can increase the risk of overdose and severe reactions.

Also see

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• JWH-018
• JWH-073